Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with Inflammatory Bowel Disease (IBD), confirmed through symptoms, scope procedures, imaging, and tissue samples
- People who are starting treatment with a medication called vedolizumab
- People who have access to a smartphone (iPhone 7 or newer, or an Android phone from 2012 or newer) with reliable internet or Wi-Fi
- People who are able to understand the study information and give consent in English or Spanish
Who may not be able to join:
- People who are not able to speak and read English or Spanish
- People who are unable to follow the study requirements, including those without reliable internet or smartphone access
- People whose insurance does not cover vedolizumab
- People who are unable to attend follow-up visits at the study site due to insurance issues or other barriers such as distance from home to the study location
- People who have had certain bowel surgeries, such as a stoma (ileostomy or colostomy) or certain types of bowel reconnection surgery
- People who are expected to have surgery within the next 60 days
- People who have a history of short bowel syndrome (a condition where much of the small intestine is missing or has been removed)
- People with certain uncontrolled medical or mental health conditions, as determined by the study doctor, including: a degenerative nerve condition, unstable chest pain (angina), poor circulation in the limbs, a cancer diagnosis within the last 2 years (not including certain common skin cancers), poorly controlled depression, mania, or schizophrenia, or a serious active infection requiring antibiotic or antifungal treatment (with some exceptions for certain IBD patients)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Raymond K Cross, MD, MS, Mercy Medical Center
Phone: 4103329356
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Medication Adherence; Self Reported Medication Adherence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.